nb100-319 Search Results


rabbit anti brca1 associated ring domain protein 1 bard1  (Novus Biologicals)
94
Novus Biologicals rabbit anti brca1 associated ring domain protein 1 bard1
MitoT increases the expression of anti-apoptotic <t>Bcl-2/BARD1</t> pathways. A Fold change of differentially expressed (DE) genes contained within the GO terms related to apoptosis, cell death, and/or responses to different stimuli. B qRT-PCR analysis of BARD1 mRNA expression levels in FACS-sorted CD3+ T cells after 24-h post-mitoception with MSC derived-MT (n = 4). C Representative western blots of BARD1 in FACS-sorted CD3+ MitoT pos cells and MitoT neg cells after 24 or 48 h post-mitoception. D Fold change quantification of proteins showed in C (n = 3). E Ingenuity Pathway analysis for Bcl-2 gene network for the DE genes denoted in A . F qRT-PCR of Bcl-2 family gene expression in FACS-sorted CD3+ MitoT pos cells and MitoT neg cells after 24 h post-mitoception (n = 4). For figures B and D : graphs show mean ± SEM and statistical analysis by unpaired t-test. For figure F : graph shows mean ± SEM and statistical analysis by unpaired Mann–Whitney test (*p < 0.05, relative to MitoT neg control). All replicates are biological
Rabbit Anti Brca1 Associated Ring Domain Protein 1 Bard1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti brca1 associated ring domain protein 1 bard1/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
rabbit anti brca1 associated ring domain protein 1 bard1 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
novus rabbit polyclonal antibody against bard1 exon 4  (Novus Biologicals)
90
Novus Biologicals novus rabbit polyclonal antibody against bard1 exon 4
MitoT increases the expression of anti-apoptotic <t>Bcl-2/BARD1</t> pathways. A Fold change of differentially expressed (DE) genes contained within the GO terms related to apoptosis, cell death, and/or responses to different stimuli. B qRT-PCR analysis of BARD1 mRNA expression levels in FACS-sorted CD3+ T cells after 24-h post-mitoception with MSC derived-MT (n = 4). C Representative western blots of BARD1 in FACS-sorted CD3+ MitoT pos cells and MitoT neg cells after 24 or 48 h post-mitoception. D Fold change quantification of proteins showed in C (n = 3). E Ingenuity Pathway analysis for Bcl-2 gene network for the DE genes denoted in A . F qRT-PCR of Bcl-2 family gene expression in FACS-sorted CD3+ MitoT pos cells and MitoT neg cells after 24 h post-mitoception (n = 4). For figures B and D : graphs show mean ± SEM and statistical analysis by unpaired t-test. For figure F : graph shows mean ± SEM and statistical analysis by unpaired Mann–Whitney test (*p < 0.05, relative to MitoT neg control). All replicates are biological
Novus Rabbit Polyclonal Antibody Against Bard1 Exon 4, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/novus rabbit polyclonal antibody against bard1 exon 4/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
novus rabbit polyclonal antibody against bard1 exon 4 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


MitoT increases the expression of anti-apoptotic Bcl-2/BARD1 pathways. A Fold change of differentially expressed (DE) genes contained within the GO terms related to apoptosis, cell death, and/or responses to different stimuli. B qRT-PCR analysis of BARD1 mRNA expression levels in FACS-sorted CD3+ T cells after 24-h post-mitoception with MSC derived-MT (n = 4). C Representative western blots of BARD1 in FACS-sorted CD3+ MitoT pos cells and MitoT neg cells after 24 or 48 h post-mitoception. D Fold change quantification of proteins showed in C (n = 3). E Ingenuity Pathway analysis for Bcl-2 gene network for the DE genes denoted in A . F qRT-PCR of Bcl-2 family gene expression in FACS-sorted CD3+ MitoT pos cells and MitoT neg cells after 24 h post-mitoception (n = 4). For figures B and D : graphs show mean ± SEM and statistical analysis by unpaired t-test. For figure F : graph shows mean ± SEM and statistical analysis by unpaired Mann–Whitney test (*p < 0.05, relative to MitoT neg control). All replicates are biological

Journal: Journal of Translational Medicine

Article Title: Survival advantage of native and engineered T cells is acquired by mitochondrial transfer from mesenchymal stem cells

doi: 10.1186/s12967-024-05627-4

Figure Lengend Snippet: MitoT increases the expression of anti-apoptotic Bcl-2/BARD1 pathways. A Fold change of differentially expressed (DE) genes contained within the GO terms related to apoptosis, cell death, and/or responses to different stimuli. B qRT-PCR analysis of BARD1 mRNA expression levels in FACS-sorted CD3+ T cells after 24-h post-mitoception with MSC derived-MT (n = 4). C Representative western blots of BARD1 in FACS-sorted CD3+ MitoT pos cells and MitoT neg cells after 24 or 48 h post-mitoception. D Fold change quantification of proteins showed in C (n = 3). E Ingenuity Pathway analysis for Bcl-2 gene network for the DE genes denoted in A . F qRT-PCR of Bcl-2 family gene expression in FACS-sorted CD3+ MitoT pos cells and MitoT neg cells after 24 h post-mitoception (n = 4). For figures B and D : graphs show mean ± SEM and statistical analysis by unpaired t-test. For figure F : graph shows mean ± SEM and statistical analysis by unpaired Mann–Whitney test (*p < 0.05, relative to MitoT neg control). All replicates are biological

Article Snippet: Then membranes were incubated with 1:1000 primary antibodies, rabbit anti-Caspase 3, or mouse anti-β-actin (Cell Signaling Technology #9662 and #3700, respectively), and rabbit anti-BRCA1-associated RING domain protein 1 (BARD1) (Novus Biological #NB100-319) and incubated overnight at 4 °C with shaking.

Techniques: Expressing, Quantitative RT-PCR, Derivative Assay, Western Blot, Gene Expression, MANN-WHITNEY, Control